MorphoSys AG
Lena-Christ-Strasse 48
Martinsried
Munich
82152
Germany
Tel: 49-0-89-899-27-0
Fax: 49-0-89-899-27-222
Website: http://www.morphosys.com/
Email: info@morphosys.com
560 articles about MorphoSys AG
-
MorphoSys AG Expands Japanese Alliance With GeneFrontier Corporation
1/25/2007
-
MorphoSys AG Enlarges Therapeutic Antibody Collaboration With Pfizer Inc. - Expansion Doubles Potential Deal Volume For MorphoSys AG
12/20/2006
-
MorphoSys AG Presents New RapMAT(TM) Antibody Technology
12/11/2006
-
MorphoSys AG And The Burnham Institute Sign Broad Research Partnership
11/28/2006
-
MorphoSys AG And Boehringer Ingelheim Corporation Expand Collaboration With New Cancer-Related Antibody Program
11/13/2006
-
MorphoSys AG And U.S. Army Enter Into Biodefense Cooperation - MorphoSys AG's AbD Serotec Awarded Sole Supplier Contract To USAMRIID
9/25/2006
-
Crucell N.V. And DSM Biologics Announce Second PER.C6 Licensing Agreement With MorphoSys AG
8/17/2006
-
AbD Serotec Opens New U.S. Office In Research Triangle Region
8/4/2006
-
MorphoSys AG Announces Expansion Of Collaboration With Novartis Corporation
6/26/2006
-
MorphoSys AG And Schering-Plough Corporation Sign R&D Agreement
5/17/2006
-
MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies
3/16/2006
-
MorphoSys AG And Roche Expand Therapeutic Antibody Partnership; MorphoSys To Receive Up To $10 Million EURO
3/1/2006
-
MorphoSys AG Achieves Fourth Therapeutic Milestone In Centocor, Inc. Collaboration
3/1/2006
-
MorphoSys AG Updates Strategy For Proprietary Product Development
2/23/2006
-
MorphoSys AG Acquires Serotec Group To Strengthen Global Research Antibody Business
1/12/2006
-
CHEMICON International, Inc. And MorphoSys AG Enter Into Worldwide Licensing Agreement For Research Antibodies
1/10/2006
-
MorphoSys AG Enters Antibody Pact With U.S. Merck & Co., Inc.
12/14/2005
-
MorphoSys AG Reports Third Quarter 2004 Results
10/28/2004
-
A Look Back At June In Biotech
7/12/2004
-
MorphoSys AG Reports First Quarter 2004 Results
4/29/2004